Invokana Interactions
There are 389 drugs known to interact with Invokana (canagliflozin), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 4 are major, 384 are moderate, and 1 is minor.
- View all 389 medications that may interact with Invokana
- View Invokana alcohol/food interactions (1)
- View Invokana disease interactions (4)
Most frequently checked interactions
View interaction reports for Invokana (canagliflozin) and the medicines listed below.
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- Crestor (rosuvastatin)
- fenofibrate
- furosemide
- gabapentin
- glimepiride
- glipizide
- hydrochlorothiazide
- Januvia (sitagliptin)
- Lantus (insulin glargine)
- Lantus SoloStar (insulin glargine)
- levothyroxine
- lisinopril
- losartan
- Lyrica (pregabalin)
- metformin
- metoprolol
- omeprazole
- Ozempic (semaglutide)
- pantoprazole
- rosuvastatin
- simvastatin
- trazodone
- Trulicity (dulaglutide)
- Victoza (liraglutide)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Invokana alcohol/food interactions
There is 1 alcohol/food interaction with Invokana (canagliflozin).
Invokana disease interactions
There are 4 disease interactions with Invokana (canagliflozin) which include:
Report options
QR code containing a link to this page
More about Invokana (canagliflozin)
- Invokana consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (257)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: SGLT-2 inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
